The B cell, arthritis, and the sympathetic nervous system

Brain, Behavior, and Immunity

Volumn 24, Issue 2, 2010, Pages 186-192

  Pongratz, Georg ^a   Straub, Rainer H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

B cell; Rheumatoid arthritis; Sympathetic nervous system

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CD86 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ENDORPHIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 4; NEUROPEPTIDE Y; NORADRENALIN; PLACEBO; RECOMBINANT INTERLEUKIN 10; RHEUMATOID FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADRENERGIC SYSTEM; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTHRITIS; B LYMPHOCYTE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; NEUROMODULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANIMALS; ARTHRITIS; B-LYMPHOCYTES; HUMANS; INFLAMMATION; NERVE ENDINGS; NEUROTRANSMITTER AGENTS; SYMPATHETIC NERVOUS SYSTEM; SYNOVIAL MEMBRANE;

EID: 72649095430     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.07.002     Document Type: Review

References (93)

1. Aho K., Heliovaara M., Maatela J., Tuomi T., and Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J. Rheumatol. 18 (1991) 1282-1284
2. Alaniz R.C., Thomas S.A., Perez-Melgosa M., Mueller K., Farr A.G., Palmiter R.D., et al. Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc. Natl. Acad. Sci. USA 96 (1999) 2274-2278
3. Apparailly F., Verwaerde C., Jacquet C., Auriault C., Sany J., and Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160 (1998) 5213-5220
4. Bas S., Genevay S., Meyer O., and Gabay C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 42 (2003) 677-680
5. Bedoui S., Kuhlmann S., Nave H., Drube J., Pabst R., and von H.S. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes. J. Neuroimmunol. 117 (2001) 125-132
6. Bedoui S., Lechner S., Gebhardt T., Nave H., Beck-Sickinger A.G., Straub R.H., et al. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J. Neuroimmunol. 132 (2002) 25-33
7. Bouaziz J.D., Yanaba K., and Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224 (2008) 201-214
8. Bouaziz J.D., Yanaba K., Venturi G.M., Wang Y., Tisch R.M., Poe J.C., et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc. Natl. Acad. Sci. USA 104 (2007) 20878-20883
9. Burkhardt H., Koller T., Engström A., Nandakumar K.S., Turnay J., Kraetsch H.G., et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 46 (2002) 2339-2348
10. Chechik B.E., Schrader W.P., Perets A., and Fernandes B. Immunohistochemical localization of adenosine deaminase in human benign extrathymic lymphoid tissues and B-cell lymphomas. Cancer 53 (1984) 70-78
11. Cho M.L., Kim W.U., Min S.Y., Min D.J., Min J.K., Lee S.H., et al. Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. Arthritis Rheum. 46 (2002) 42-51
12. Constant S., Schweitzer N., West J., Ranney P., and Bottomly K. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J. Immunol. 155 (1995) 3734-3741
13. Coqueret O., Lagente V., Frere C.P., Braquet P., and Mencia-Huerta J.M. Regulation of IgE production by beta 2-adrenoceptor agonists. Ann. NY Acad. Sci. 725 (1994) 44-49
14. Cush J.J., Splawski J.B., Thomas R., McFarlin J.E., Schulze-Koops H., Davis L.S., et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 38 (1995) 96-104
15. Davidson H.W., and Watts C. Epitope-directed processing of specific antigen by B lymphocytes. J. Cell Biol. 109 (1989) 85-92
16. Dekkers J.C., Geenen R., Godaert G.L., Bijlsma J.W., and van Doornen L.J. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin. Exp. Rheumatol. 22 (2004) 63-70
17. Edvinsson L., Erlinge D., Sun X.Y., and Hedner T. Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists. Pharmacol. Toxicol. 74 (1994) 193-201
18. Edwards J.C., Szczepanski L., Szechinski J., Filipowicz-Sosnowska A., Emery P., Close D.R., et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350 (2004) 2572-2581
19. Ekblad E., Edvinsson L., Wahlestedt C., Uddman R., Hakanson R., and Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul. Pept. 8 (1984) 225-235
20. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178 (2007) 7868-7878
21. Fried G., Terenius L., Brodin E., Efendic S., Dockray G., Fahrenkrug J., et al. Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Biochemical and immunohistochemical evidence. Cell Tissue Res. 243 (1986) 495-508
22. Fried G., Terenius L., Hokfelt T., and Goldstein M. Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J. Neurosci. 5 (1985) 450-458
23. Gaveriaux C., Peluso J., Simonin F., Laforet J., and Kieffer B. Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett. 369 (1995) 272-276
24. Halldorsdottir H.D., Jonsson T., Thorsteinsson J., and Valdimarsson H. A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor. Ann. Rheum. Dis. 59 (2000) 149-151
25. Harizi H., and Gualde N. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell. Mol. Immunol. 3 (2006) 271-277
26. Härle P., Möbius D., Carr D.J., Schölmerich J., and Straub R.H. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum. 52 (2005) 1305-1313
27. Heagy W., Shipp M.A., and Finberg R.W. Opioid receptor agonists and Ca2+ modulation in human B cell lines. J. Immunol. 149 (1992) 4074-4081
28. Janeway Jr. C.A., Ron J., and Katz M.E. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 138 (1987) 1051-1055
29. Kasprowicz D.J., Kohm A.P., Berton M.T., Chruscinski A.J., Sharpe A., and Sanders V.M. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. J. Immunol. 165 (2000) 680-690
30. Kennedy C., McLaren G.J., Westfall T.D., and Sneddon P. ATP as a co-transmitter with noradrenaline in sympathetic nerves-function and fate. Ciba Found. Symp. 198 (1996) 223-235
31. Kin N.W., and Sanders V.M. It takes nerve to tell T and B cells what to do. J. Leukoc. Biol. 79 (2006) 1093-1104
32. Kohm A.P., and Sanders V.M. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J. Immunol. 162 (1999) 5299-5308
33. Kohm A.P., and Sanders V.M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53 (2001) 487-525
34. Kuis W., de Jong-de Vos van Steenwijk C., Sinnema G., Kavelaars A., Prakken B., Helders P.J., et al. The autonomic nervous system and the immune system in juvenile rheumatoid arthritis. Brain Behav. Immun. 10 (1996) 387-398
35. Kurt-Jones E.A., Liano D., HayGlass K.A., Benacerraf B., Sy M.S., and Abbas A.K. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J. Immunol. 140 (1988) 3773-3778
36. Li G., Harton J.A., Zhu X., and Ting J.P. Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines. Mol. Cell. Biol. 21 (2001) 4626-4635
37. Liang B., and Mamula M.J. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens. Cell. Mol. Life Sci. 57 (2000) 561-568
38. Liopeta K., Boubali S., Virgilio L., Thyphronitis G., Mavrothalassitis G., Dimitracopoulos G., et al. CAMP regulates IL-10 production by normal human T lymphocytes at multiple levels: a potential role for MEF2. Mol. Immunol. 46 (2009) 345-354
39. Lund F.E. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 20 (2008) 332-338
40. Lundberg J.M., Rudehill A., Sollevi A., Fried G., and Wallin G. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 28 (1989) 475-486
41. Luther S.A., Lopez T., Bai W., Hanahan D., and Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12 (2000) 471-481
42. Magalhaes R., Stiehl P., Morawietz L., Berek C., and Krenn V. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch. 441 (2002) 415-427
43. Maini R.N., Paulus H., Breedveld F.C., Moreland L.W., St Clair E.W., Rusell A.S., et al. rHUIL-10 in subjects with active rheumatoid arthritis (RA): a phase I and cytokine response study. Arthritis Rheum. 40 (1997) S224
44. Mauri C., Gray D., Mushtaq N., and Londei M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197 (2003) 489-501
45. McAlees J.W., and Sanders V.M. Hematopoietic protein tyrosine phosphatase mediates beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes. Mol. Cell. Biol. 29 (2009) 675-686
46. McGovern E.M., Moquin A.E., Caballero A., and Drake J.R. The effect of B cell receptor signaling on antigen endocytosis and processing. Immunol. Invest. 33 (2004) 143-156
47. Miller L.E., Grifka J., Schölmerich J., and Straub R.H. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J. Rheumatol. 29 (2002) 427-435
48. Miller L.E., Justen H.P., Schölmerich J., and Straub R.H. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 14 (2000) 2097-2107
49. Miller L.E., Weidler C., Falk W., Angele P., Schaumburger J., Schölmerich J., et al. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 50 (2004) 1156-1163
50. Minguet S., Huber M., Rosenkranz L., Schamel W.W., Reth M., and Brummer T. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur. J. Immunol. 35 (2005) 31-41
51. Mizoguchi A., and Bhan A.K. A case for regulatory B cells. J. Immunol. 176 (2006) 705-710
52. Moore S., Ruska K., Peters L., and Olsen N.J. Associations of IgA and IgA-rheumatoid factor with disease features in patients with rheumatoid arthritis. Immunol. Invest. 23 (1994) 355-365
53. Morgan E.L. Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists. J. Neuroimmunol. 65 (1996) 21-30
54. Morgan E.L., McClurg M.R., and Janda J.A. Suppression of human B lymphocyte activation by beta-endorphin. J. Neuroimmunol. 28 (1990) 209-217
55. Nance D.M., and Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav. Immun. 21 (2007) 736-745
56. Nandakumar K.S., Backlund J., Vestberg M., and Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res. Ther. 6 (2004) R544-R550
57. Napieralski R., Kempkes B., and Gutensohn W. Evidence for coordinated induction and repression of ecto-5′-nucleotidase (CD73) and the A2a adenosine receptor in a human B cell line. Biol. Chem. 384 (2003) 483-487
58. Newkirk M.M. Rheumatoid factors: host resistance or autoimmunity?. Clin. Immunol. 104 (2002) 1-13
59. Nielen M.M., van S.D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50 (2004) 380-386
60. Pablo Huidobro-Toro J., and Veronica D.M. Sympathetic co-transmission: the coordinated action of ATP and noradrenaline and their modulation by neuropeptide Y in human vascular neuroeffector junctions. Eur. J. Pharmacol. 500 (2004) 27-35
61. Persson S., Mikulowska A., Narula S., O'Garra A., and Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand. J. Immunol. 44 (1996) 607-614
62. Petitto J.M., Huang Z., and McCarthy D.B. Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J. Neuroimmunol. 54 (1994) 81-86
63. Platzer C., Fritsch E., Elsner T., Lehmann M.H., Volk H.D., and Prosch S. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur. J. Immunol. 29 (1999) 3098-3104
64. Podojil J.R., Kin N.W., and Sanders V.M. CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3′-IgH enhancer in B cells. J. Biol. Chem. 279 (2004) 23394-23404
65. Pongratz G., McAlees J.W., Conrad D.H., Erbe R.S., Haas K.M., and Sanders V.M. The level of IgE produced by a B cell is regulated by norepinephrine in a p38. J. Immunol. 177 (2006) 2926-2938
66. Resta R., Yamashita Y., and Thompson L.F. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol. Rev. 161 (1998) 95-109
67. Rodriguez-Pinto D. B cells as antigen presenting cells. Cell. Immunol. 238 (2005) 67-75
68. Ron Y., and Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 138 (1987) 2848-2856
69. Roy S., Ge B.L., Ramakrishnan S., Lee N.M., and Loh H.H. [3H]morphine binding is enhanced by IL-1-stimulated thymocyte proliferation. FEBS Lett. 287 (1991) 93-96
70. Ruschpler P., and Stiehl P. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA). Cell. Mol. Biol. (Noisy.-le-grand) 48 (2002) 285-293
71. Sakata N., Kawasome H., Terada N., Johnson G.L., and Gelfand E.W. CD40 and adenosine A2 receptor agonist-cyclic adenosine monophosphate rescue B-cell antigen receptor-induced apoptosis through independent pathways and converge to prevent caspase activation. J. Allergy Clin. Immunol. 105 (2000) 522-531
72. Sanders V.M., Kasprowicz D.J., Swanson-Mungerson M.A., Podojil J.R., and Kohm A.P. Adaptive immunity in mice lacking the beta(2)-adrenergic receptor. Brain Behav. Immun. 17 (2003) 55-67
73. Scofield R.H. Autoantibodies as predictors of disease. Lancet 363 (2004) 1544-1546
74. Shahabi N.A., Linner K.M., and Sharp B.M. Murine splenocytes express a naloxone-insensitive binding site for beta-endorphin. Endocrinology 126 (1990) 1442-1448
75. Sharp B.M. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav. Immun. 20 (2006) 9-14
76. Snider D.P., and Segal D.M. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells. J. Immunol. 143 (1989) 59-65
77. Sun J., Lin Z., Feng J., Li Y., and Shen B. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases. Eur. J. Pharmacol. 597 (2008) 1-5
78. Tanaka H., Ueta Y., Yamashita U., Kannan H., and Yamashita H. Biphasic changes in behavioral, endocrine, and sympathetic systems in adjuvant arthritis in Lewis rats. Brain Res. Bull. 39 (1996) 33-37
79. Tanaka Y., Otsuka T., Hotokebuchi T., Miyahara H., Nakashima H., Kuga S., et al. Effect of IL-10 on collagen-induced arthritis in mice. Inflamm. Res. 45 (1996) 283-288
80. Teitsson I., Withrington R.H., Seifert M.H., and Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann. Rheum. Dis. 43 (1984) 673-678
81. Tian H., and Cronstein B.N. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp. Jt. Dis. 65 (2007) 168-173
82. Todorov L.D., Mihaylova-Todorova S., Craviso G.L., Bjur R.A., and Westfall D.P. Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens. J. Physiol. 496 Pt 3 (1996) 731-748
83. Torres G., Bitran M., and Huidobro-Toro J.P. Co-release of neuropeptide Y (NPY) and noradrenaline from the sympathetic nerve terminals supplying the rat vas deferens; influence of calcium and the stimulation intensity. Neurosci. Lett. 148 (1992) 39-42
84. Trachsel E., Bootz F., Silacci M., Kaspar M., Kosmehl H., and Neri D. Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis. Arthritis Res. Ther. 9 (2007) R9
85. van der Stoep N., Quinten E., and van den Elsen P.J. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5′-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes. J. Immunol. 169 (2002) 5061-5071
86. von Kugelgen I., and Starke K. Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol. Sci. 12 (1991) 319-324
87. Walker J.S. Anti-inflammatory effects of opioids. Adv. Exp. Med. Biol. 521 (2003) 148-160
88. Walmsley M., Katsikis P.D., Abney E., Parry S., Williams R.O., Maini R.N., et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum. 39 (1996) 495-503
89. Watts C., and Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J. Exp. Med. 178 (1993) 1459-1463
90. Weyand C.M., Seyler T.M., and Goronzy J.J. B cells in rheumatoid synovitis. Arthritis Res.Ther. 7 Suppl. 3 (2005) S9-12
91. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., and Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28 (2008) 639-650
92. Zhu X.S., Linhoff M.W., Li G., Chin K.C., Maity S.N., and Ting J.P. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell. Biol. 20 (2000) 6051-6061
93. Zukowska-Grojec Z., and Wahlestedt C. Origin and actions of NPY in the cardiovascular system. In: Colmers Y.W.F., and Wahlestedt C. (Eds). Biology of Neuropeptides (1993), Humana Press, Totowa 325-326